INTELLINETICS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that INTELLINETICS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2017 | $2.62M | Apr 1, 2019 |
| FY2011 | Dec 31, 2011 | $0 | Jan 31, 2012 |
| FY2011 | Dec 31, 2010 | $0 | Jan 31, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.58M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $18.02M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $16.89M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $14.02M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $11.46M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $8.25M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.54M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $2.38M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $2.62M | Apr 1, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.62M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $2.60M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $2.34M | Mar 30, 2017 |
| FY2015 | Dec 31, 2014 | $1.49M | Mar 28, 2016 |
| FY2014 | Dec 31, 2013 | $1.55M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $2.73M | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $1.73M | Apr 1, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.95M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $11.37M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $10.56M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $8.91M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $6.94M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $4.99M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.97M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $1.64M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $1.86M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.89M | Apr 2, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.87M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($546.2K) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $519.3K | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $24.0K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.36M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | ($2.20M) | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($2.13M) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($2.34M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($1.37M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($1.58M) | Apr 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.79M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($173.5K) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $1.11M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $827.3K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $965.0K | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | ($2.04M) | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($1.15M) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($1.47M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($1.17M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($1.37M) | Apr 2, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $293.1K | Mar 30, 2021 |
| FY2020 | Dec 31, 2019 | $467.4K | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $359.8K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $412.4K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $386.3K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $498.0K | Mar 30, 2017 |
| FY2015 | Dec 31, 2014 | $407.7K | Mar 28, 2016 |
| FY2014 | Dec 31, 2013 | $285.8K | Mar 31, 2015 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $933.9K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $3.86M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $784.7K | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $1.99M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.39M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $125.0K | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($982.2K) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($1.16M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($1.12M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($1.26M) | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $354.4K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $439.2K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $111.2K | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $201.0K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $552.2K | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $76.9K | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $5.5K | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $3.4K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $12.6K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $6.9K | Apr 2, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.31M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $18.57M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $19.03M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $19.94M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $11.96M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $10.34M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $986.6K | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $1.41M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $1.61M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.13M | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.92M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $7.94M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $9.28M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $11.37M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $9.30M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $9.19M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $7.36M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $5.94M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $4.25M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.09M | Apr 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.38M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $10.63M | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $9.75M | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | $8.57M | Mar 24, 2025 |
| FY2023 | Dec 31, 2021 | $2.66M | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | $1.15M | Mar 27, 2023 |
| FY2021 | Dec 31, 2019 | ($6.38M) | Mar 24, 2022 |
| FY2020 | Dec 31, 2018 | ($4.53M) | Mar 30, 2021 |
| FY2019 | Dec 31, 2017 | ($2.64M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | ($1.96M) | Apr 1, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.79M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $5.79M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $5.79M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $5.79M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.32M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $2.32M | Mar 24, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($23.51M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($21.64M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($21.10M) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | ($21.61M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($21.64M) | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | ($23.00M) | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($20.80M) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($18.66M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($16.32M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($14.95M) | Apr 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.49M | Mar 24, 2025 |
| FY2024 | Dec 31, 2023 | $1.22M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $2.70M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.75M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $1.91M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $404.2K | Mar 30, 2021 |
| FY2011 | Dec 31, 2011 | $68 | Jan 31, 2012 |
| FY2011 | Dec 31, 2010 | $1.3K | Jan 31, 2012 |
| FY2011 | Dec 31, 2009 | $305 | Jan 31, 2012 |
| FY2011 | Oct 2, 1997 | $0 | Jan 31, 2012 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $3.34M | Mar 27, 2023 |
| FY2021 | Dec 31, 2021 | $2.00M | Mar 24, 2022 |
| FY2020 | Dec 31, 2020 | $2.84M | Mar 30, 2021 |
| FY2019 | Dec 31, 2019 | $3.54M | Mar 30, 2020 |
| FY2018 | Dec 31, 2018 | $3.54M | Apr 1, 2019 |
| FY2017 | Dec 31, 2017 | $2.45M | Apr 2, 2018 |
| FY2016 | Dec 31, 2016 | $980.3K | Mar 30, 2017 |
| FY2014 | Dec 27, 2013 | $160.0K | Mar 31, 2015 |
| FY2014 | Nov 12, 2013 | $160.0K | Mar 31, 2015 |
| FY2014 | Feb 4, 2013 | $350.0K | Mar 31, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 24, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 24, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.48M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 4.25M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 4.11M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | 4.07M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 2.82M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | 2.81M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | 370,497 | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | 354,588 | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 17.43M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 16.82M | Apr 2, 2018 |